Benner Joshua S, Becker Russell, Fanning Kristina, Jumadilova Zhanna, Bavendam Tamara, Brubaker Linda
ValueMedics Research, L. L. C., Falls Church, Virginia, USA.
J Urol. 2009 Jun;181(6):2591-8. doi: 10.1016/j.juro.2009.02.018. Epub 2009 Apr 16.
We measured patient reported bother due to overactive bladder syndrome, patterns of physician consultation and prescription medication use for overactive bladder symptoms in adults in the United States.
A survey sample was derived from a consumer panel of 600,000 American households developed to match the United States Census of 260,000 adults. The survey included the Overactive Bladder-Validated 8 awareness tool, which includes 8 questions that measure the degree of bother due to specific bladder symptoms. A score of 8 or greater denotes probable overactive bladder. Additional questions probed treatment patterns, health care consultation, overactive bladder diagnosis, treatment type and prescription treatment used. A nonrespondent telephone survey in 1,004 participants was done to evaluate differences between mail survey respondents and nonrespondents.
The response rate was 63% (162,906 respondents). Women represented 55.1% of the sample and 21.8% of respondents were 65 years old or older. Symptom bother, as determined by an Overactive Bladder-Validated 8 score of 8 or greater, was reported by 26.6% of the total sample, including 23.7% of men and 28.9% of women. The percent of men and women reporting bother increased with age. Of respondents with probable overactive bladder only 45.7% had discussed the symptoms with a medical provider, 22.5% had previously used prescription medication for overactive bladder, 13.5% had used overactive bladder medication in the last 12 months and 8.1% were currently on treatment.
A substantial proportion of adults in the United States reported some degree of bother due to overactive bladder symptoms. The degree of bother was associated with age and gender. Overall less than half of patients with probable overactive bladder discussed the symptoms with a health care provider. A small proportion was prescribed medication and an even smaller proportion was currently on treatment.
我们在美国成年人中测量了因膀胱过度活动症导致的患者报告的困扰、医生咨询模式以及用于膀胱过度活动症症状的处方药使用情况。
调查样本取自一个由60万户美国家庭组成的消费者小组,该小组是为匹配美国26万成年人的人口普查数据而建立的。该调查包括膀胱过度活动症验证8项认知工具,其中包含8个问题,用于测量特定膀胱症状导致的困扰程度。得分8分及以上表示可能患有膀胱过度活动症。其他问题则探究了治疗模式、医疗咨询、膀胱过度活动症诊断、治疗类型以及使用的处方治疗方法。对1004名参与者进行了无回应电话调查,以评估邮寄调查受访者与未受访者之间的差异。
回应率为63%(162,906名受访者)。女性占样本的55.1%,21.8%的受访者年龄在65岁及以上。总样本中有26.6%的人报告有症状困扰,根据膀胱过度活动症验证8项得分8分及以上确定,其中男性为23.7%,女性为28.9%;报告有困扰的男性和女性比例随年龄增长而增加。在可能患有膀胱过度活动症的受访者中,只有45.7%的人曾与医疗服务提供者讨论过症状,22.5%的人此前曾使用过治疗膀胱过度活动症的处方药,13.5%的人在过去12个月内使用过膀胱过度活动症药物,8.1%的人目前正在接受治疗。
美国相当一部分成年人报告因膀胱过度活动症症状而有一定程度的困扰。困扰程度与年龄和性别有关。总体而言,可能患有膀胱过度活动症的患者中不到一半的人与医疗服务提供者讨论过症状。只有一小部分人被开了药,而目前正在接受治疗的比例更小。